文献速递白血病

持续存在的缓解后克隆性造血塑造急性髓系白血病的复发轨迹

Persistent postremission clonal hematopoiesis shapes the relapse trajectories of acute myeloid leukemia.
PubMed 文献 · Blood Adv · 2025-01-01

该回顾性队列纳入本机构182例初诊急性髓系白血病患者,在诊断、缓解和/或复发时进行基因组测序。研究发现FLT3和NPM1突变在完全缓解时通常被清除但复发时重新出现,而DNMT3A、TET2和ASXL1突变常持续贯穿缓解期。克隆性造血相关突变具有独特的共现基因改变组合,并塑造了AML从诊断、治疗到复发的演化轨迹。

要点

  • FLT3和NPM1突变在完全缓解时通常被清除,但复发时重新出现。
  • DNMT3A、TET2和ASXL1突变常持续贯穿缓解期。
  • NPM1和FLT3突变富集于DNMT3A突变AML,CBL和SRSF2突变分别富集于TET2突变和ASXL1突变AML。

核心结论

  • 可能先于恶性转化的克隆性造血相关突变通过诊断、治疗和复发塑造了AML的演化轨迹。

研究设计与样本

  • 本机构初诊急性髓系白血病患者的回顾性队列,共182例,在诊断、缓解和/或复发时进行基因组测序。

主要发现

  • FLT3和NPM1突变在完全缓解时通常被清除,但随后在复发时重新出现。
  • DNMT3A、TET2和ASXL1突变常持续贯穿缓解期。
  • NPM1和FLT3突变富集于DNMT3A突变AML,CBL和SRSF2突变分别富集于TET2突变和ASXL1突变AML。
  • NPM1和FLT3突变的差异在完全缓解时消失,但在复发时重新出现,表明这些遗传相互作用具有可重复性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mutations found in acute myeloid leukemia (AML) such as DNMT3A, TET2, and ASXL1 can be found in the peripheral blood of healthy adults, a phenomenon termed clonal hematopoiesis (CH). These mutations are thought to represent the earliest genetic events in the evolution of AML. Genomic studies on samples acquired at diagnosis, remission, and at relapse have demonstrated significant stability of CH mutations after induction chemotherapy. Meanwhile, later mutations in genes such as NPM1 and FLT3 have been shown to contract at remission, and in the case of FLT3 often are absent at relapse. We sought to understand how early CH mutations influence subsequent evolutionary trajectories throughout remission and relapse in response to induction chemotherapy. We assembled a retrospective cohort of patients diagnosed with de novo AML at our institution that underwent genomic sequencing at diagnosis, remission, and/or relapse (total N = 182 patients). FLT3 and NPM1 mutations were generally eliminated at complete remission but subsequently reemerged upon relapse, whereas DNMT3A, TET2, and ASXL1 mutations often persisted through remission. CH-related mutations exhibited distinct constellations of co-occurring genetic alterations, with NPM1 and FLT3 mutations enriched in DNMT3Amut AML, whereas CBL and SRSF2 mutations were enriched in TET2mut and ASXL1mut AML, respectively. In the case of NPM1 and FLT3 mutations, these differences vanished at the time of complete remission yet readily reemerged upon relapse, indicating the reproducible nature of these genetic interactions. Thus, CH-associated mutations that likely precede malignant transformation subsequently shape the evolutionary trajectories of AML through diagnosis, therapy, and relapse.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Chow RD, Velu P, Deihimi S, et al. Persistent postremission clonal hematopoiesis shapes the relapse trajectories of acute myeloid leukemia. Blood Adv. 2025. PMID: 39938015. doi:10.1182/bloodadvances.2024015149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。